The self-assembling peptide (KLDL) 3 , or KLD, has been shown to have chondrogenic properties in vitro. In addition, TGF-β1 and dexamethasone are crucial for inducing chondrogenesis of bone marrow-derived stromal cells (BMSCs) in vitro, and IGF-1 promotes biosynthesis of sGAGs by chondrocytes. The goal of this study was to optimize conditions to provide the best repair in a rabbit model. Methods: In Vitro Tissue Engineering: Bone marrow was harvested from bovine calves. BMSCs were selected via differential adhesion and expanded 2 passages in LGDMEM with 10% FBS & 5ng/mL FGF-2. KLD peptide (0.35% w/v) was pre-mixed with 100ng/mL TGF-β1 and 100nM dexamethasone, with or without 300 ng/mL IGF-1, prior to adding cells. BMSCs were encapsulated in KLD/GF mixture at 10 million/mL. Gels were cultured in 1% ITS + HGDMEM. sGAG retained in each hydrogel was quantified by DMMB dye binding. DNA was quantified by Hoechst dye assay. During the final 24 h of culture, 5μ Ci/mL 35 S-sulfate and 10μ Ci/mL 3 H-proline was added to medium to quantify proteoglycan (PG) and protein synthesis. In Vivo Rabbit Model: Three different conditions were tested: KLD alone, KLD + GF, and KLD + GF + BMSCs. Based on the in vitro study, 100ng/mL TGF-β1, 100 nM dexamethasone, and 300 ng/mL IGF-1 were used together as the growth factor (GF) combination pre-mixed with KLD prior to injection. BMSCs were allogenic. In 32 female 8-month-old New Zealand White rabbits, a 3mm diameter full-thickness defect was created in the femoropatellar groove of each knee. GF and cells were pre-mixed with KLD and directly injected into left-knee defects with right-knee defects left empty as controls. There were 6-7 rabbits used for each condition. ACUC approval was given by CSU. Repair tissue was analyzed by gross and histological scoring. Results: In vitro testing confirmed that including IGF-1, along with TGF-β1 and dexamethasone, improved chondrogenesis of BMSCs in KLD as shown by higher sGAG content and PG synthesis (Fig. 1) . However, in the rabbit model, the KLD group without any growth factors or cells showed the greatest repair after 12 weeks. KLD had a significantly higher total histology score and more Safranin-O staining (Fig. 2, 3 ). Including BMSCs with GF resulted
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The self-assembling peptide (KLDL) 3 , or KLD, has been shown to have chondrogenic properties in vitro. In addition, TGF-β1 and dexamethasone are crucial for inducing chondrogenesis of bone marrow-derived stromal cells (BMSCs) in vitro, and IGF-1 promotes biosynthesis of sGAGs by chondrocytes. The goal of this study was to optimize conditions to provide the best repair in a rabbit model. Methods: In Vitro Tissue Engineering: Bone marrow was harvested from bovine calves. BMSCs were selected via differential adhesion and expanded 2 passages in LGDMEM with 10% FBS & 5ng/mL FGF-2. KLD peptide (0.35% w/v) was pre-mixed with 100ng/mL TGF-β1 and 100nM dexamethasone, with or without 300 ng/mL IGF-1, prior to adding cells. BMSCs were encapsulated in KLD/GF mixture at 10 million/mL. Gels were cultured in 1% ITS + HGDMEM. sGAG retained in each hydrogel was quantified by DMMB dye binding. DNA was quantified by Hoechst dye assay. During the final 24 h of culture, 5μ Ci/mL 35 S-sulfate and 10μ Ci/mL 3 H-proline was added to medium to quantify proteoglycan (PG) and protein synthesis. In Vivo Rabbit Model: Three different conditions were tested: KLD alone, KLD + GF, and KLD + GF + BMSCs. Based on the in vitro study, 100ng/mL TGF-β1, 100 nM dexamethasone, and 300 ng/mL IGF-1 were used together as the growth factor (GF) combination pre-mixed with KLD prior to injection. BMSCs were allogenic. In 32 female 8-month-old New Zealand White rabbits, a 3mm diameter full-thickness defect was created in the femoropatellar groove of each knee. GF and cells were pre-mixed with KLD and directly injected into left-knee defects with right-knee defects left empty as controls. There were 6-7 rabbits used for each condition. ACUC approval was given by CSU. Repair tissue was analyzed by gross and histological scoring. Results: In vitro testing confirmed that including IGF-1, along with TGF-β1 and dexamethasone, improved chondrogenesis of BMSCs in KLD as shown by higher sGAG content and PG synthesis (Fig. 1) . However, in the rabbit model, the KLD group without any growth factors or cells showed the greatest repair after 12 weeks. KLD had a significantly higher total histology score and more Safranin-O staining (Fig. 2, 3 ). Including BMSCs with GF resulted in significantly lower surface regularity scores compared to KLD or KLD+GFs and significantly more osteophyte formation than KLD (Fig. 3) . In all groups, treated defects resulted in a larger percent volume filled and lower muscle wastage compared to untreated defects (Fig. 3) . There was no inflammatory response among any conditions. Conclusions: Premixing KLD with IGF-1, TGF-β1, and dexamethasone in vitro resulted in more ECM production compared to TGF-β1 and dexamethasone alone. In a rabbit model, KLD provided a cartilage-like repair with an improved total histology score and increased Safranin-O staining compared to the bilateral control empty defect. GF/BMSC interactions in vivo may differ from in vitro model conditions and may explain differences in results.
ADSORBING TGF-β1 TO SELF-ASSEMBLING PEPTIDE SCAFFOLDS ENHANCES BMSC CHONDROGENESIS
E.J. Vanderploeg, P.W. Kopesky, S. Byun, A.J. Grodzinsky MIT, Cambridge, MA Purpose: Bone marrow progenitor cells (BMSCs) are a promising cell source for cartilage tissue engineering. Self-assembling peptide hydrogels are a relatively new class of biomaterials being studied for cartilage regeneration. A potential difficulty for translating in vitro techniques using BMSCs to animal studies or clinical applications is that growth factors, such as TGF-β1 (TGF), are necessary to drive BMSC chondrogenesis. However, repeated growth factor delivery in vivo is time and cost prohibitive, and excess growth factor can cause systemic complications. Thus, the objective of these studies was to evaluate the potential of self-assembling peptide hydrogels to retain TGF and stimulate chondrogenic differentiation of BMSCs in vitro. Methods: Uptake Ratio 125 I labeled TGF was adsorbed to KLD peptide by mixing prior to assembly or adding it to the bath after assembly. Acellular gels were cultured for 7 days to reach equilibrium and the ratio of 125 I-TGF concentration in the gel to that in the bath was evaluated. Cell Culture BMSCs were isolated from 2-5 year old horses and expanded in 10% FBS and 5ng/mL bFGF. BMSCs were encapsulated in KLD peptide hydrogels at 10×10 6 cells/mL and cultured in basal medium (hg-DMEM, 1% ITS+, 37.5 μg/mL A2P, & 100nM dexamethasone) with or without 10ng/mL TGF. For the "TGF-takeaway" study, groups of gels cultured in TGF medium were switched to basal medium after 4, 7, or 14 days. All gels were cultured for 21 days total. In the "TGF-adsorbed" study, 100ng/mL TGF was adsorbed to soluble KLD peptide prior to cell encapsulation. These gels (KLD-Ad) were then cultured in basal medium alongside KLD gels in either basal (Basal) or TGF supplemented (TGF) medium for up to 21 days. Data were analyzed with ANOVA and Tukey's test for post-hoc comparisons with significance at p<0.05. Results: The uptake ratio ([TGF] in gel: [TGF] in medium) was greater than 1 in both cases; however when TGF was adsorbed onto KLD peptide prior to assembly the uptake ratio was significantly higher than when TGF was added to the medium post assembly (Fig. 1) . Only 4 days of TGF in the medium was sufficient to stimulate BMSC chondrogenesis; furthermore gels with TGF in the medium for 14 days showed no differences from gels with TGF in the medium for the entire culture period ( Fig. 2A & B) . Interestingly, when TGF was adsorbed to the KLD peptide prior Figure 1 .
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